Denis Cournoyer

1.9k total citations
42 papers, 1.5k citations indexed

About

Denis Cournoyer is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Denis Cournoyer has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Genetics. Recurrent topics in Denis Cournoyer's work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Denis Cournoyer is often cited by papers focused on Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Denis Cournoyer collaborates with scholars based in Canada, United States and United Kingdom. Denis Cournoyer's co-authors include Terry Chow, Clifford P. Stanners, Nicole Beauchemin, Sarita Benchimol, Chantal Séguin, Mohammad Amin Kerachian, Edward J. Harvey, A Fuks, Nicoletta Eliopoulos and Richard L. Momparler and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Annual Review of Immunology.

In The Last Decade

Denis Cournoyer

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Cournoyer Canada 23 708 434 343 304 284 42 1.5k
John Marken United States 9 607 0.9× 294 0.7× 587 1.7× 78 0.3× 250 0.9× 13 1.5k
Jon C. Jones United States 16 712 1.0× 1.1k 2.6× 81 0.2× 247 0.8× 345 1.2× 25 1.7k
P H Wiernik United States 23 369 0.5× 847 2.0× 441 1.3× 78 0.3× 76 0.3× 70 1.8k
Olivier Spertini Switzerland 21 714 1.0× 333 0.8× 570 1.7× 204 0.7× 84 0.3× 32 2.3k
H. Poliwoda Germany 23 332 0.5× 660 1.5× 344 1.0× 95 0.3× 126 0.4× 139 1.8k
Inger Marie S. Dahl Norway 20 696 1.0× 427 1.0× 1.1k 3.2× 60 0.2× 124 0.4× 37 1.7k
V von Fliedner Switzerland 22 411 0.6× 881 2.0× 330 1.0× 381 1.3× 90 0.3× 54 2.1k
Yataro Yoshida Japan 18 404 0.6× 177 0.4× 664 1.9× 42 0.1× 131 0.5× 85 1.1k
ED Ball United States 22 548 0.8× 325 0.7× 911 2.7× 147 0.5× 143 0.5× 47 1.5k

Countries citing papers authored by Denis Cournoyer

Since Specialization
Citations

This map shows the geographic impact of Denis Cournoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Cournoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Cournoyer more than expected).

Fields of papers citing papers by Denis Cournoyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Cournoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Cournoyer. The network helps show where Denis Cournoyer may publish in the future.

Co-authorship network of co-authors of Denis Cournoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Cournoyer. A scholar is included among the top collaborators of Denis Cournoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Cournoyer. Denis Cournoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, Charles L., Karen M. Starko, Henrik S. Thomsen, et al.. (2012). Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye’s Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR). Journal of General Internal Medicine. 27(12). 1697–1703. 16 indexed citations
2.
Kerachian, Mohammad Amin, Edward J. Harvey, Denis Cournoyer, et al.. (2011). A rat model of early stage osteonecrosis induced by glucocorticoids. Journal of Orthopaedic Surgery and Research. 6(1). 62–62. 23 indexed citations
3.
Kerachian, Mohammad Amin, Denis Cournoyer, Edward J. Harvey, et al.. (2010). New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model. Arthritis Research & Therapy. 12(3). R124–R124. 48 indexed citations
4.
Kerachian, Mohammad Amin, Denis Cournoyer, Edward J. Harvey, et al.. (2009). Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion. The Journal of Steroid Biochemistry and Molecular Biology. 116(3-5). 127–133. 37 indexed citations
5.
McKoy, June M., Denis Cournoyer, Jérôme Rossert, et al.. (2008). Epoetin‐associated pure red cell aplasia: past, present, and future considerations. Transfusion. 48(8). 1754–1762. 135 indexed citations
6.
Kerachian, Mohammad Amin, Denis Cournoyer, Edward J. Harvey, Terry Chow, & Chantal Séguin. (2007). Isolation and Characterization of Human Bone-Derived Endothelial Cells. Endothelium. 14(2). 115–121. 8 indexed citations
7.
Belzile, Jean-Philippe, Sibgat Choudhury, Denis Cournoyer, & Terry Chow. (2006). Targeting DNA Repair Proteins: A Promising Avenue for Cancer Gene Therapy. Current Gene Therapy. 6(1). 111–123. 22 indexed citations
8.
Kerachian, Mohammad Amin, Edward J. Harvey, Denis Cournoyer, Terry Chow, & Chantal Séguin. (2006). Avascular Necrosis of the Femoral Head: Vascular Hypotheses. Endothelium. 13(4). 237–244. 145 indexed citations
9.
Cournoyer, Denis, Edwin B. Toffelmire, George A. Wells, et al.. (2004). Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products. Journal of the American Society of Nephrology. 15(10). 2728–2734. 58 indexed citations
11.
Semionov, Alexandre, Denis Cournoyer, & Terry Chow. (2003). 1,5-isoquinolinediol increases the frequency of gene targeting by homologous recombination in mouse fibroblasts. Biochemistry and Cell Biology. 81(1). 17–24. 9 indexed citations
13.
Glass, Kathleen Cranley, Charles Weijer, Denis Cournoyer, et al.. (1999). Structuring the Review of Human Genetics Protocols. Likarska sprava. 100–4. 2 indexed citations
14.
Semionov, Alexandre, Denis Cournoyer, & Terry Chow. (1999). Inhibition of poly(ADP-ribose)polymerase stimulates extrachromosomal homologous recombination in mouse Ltk- fibroblasts. Nucleic Acids Research. 27(22). 4526–4531. 13 indexed citations
15.
Semionov, Alexandre, Denis Cournoyer, & Terry Chow. (1999). The effect of the Saccharomyces cerevisiae endo-exonuclease NUD1 gene expression on the resistance of HeLa cells to DNA-damaging agents. Mutation Research/DNA Repair. 433(3). 169–181. 9 indexed citations
16.
Eliopoulos, Nicoletta, Denis Cournoyer, & Richard L. Momparler. (1998). Drug resistance to 5-aza-2 ′ -deoxycytidine, 2 ′ ,2 ′ -difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. Cancer Chemotherapy and Pharmacology. 42(5). 373–378. 77 indexed citations
17.
Asefa, Benyam, et al.. (1998). Genetic analysis of the yeast NUD1 endo-exonuclease: a role in the repair of DNA double-strand breaks. Current Genetics. 34(5). 360–367. 13 indexed citations
18.
Momparler, Richard L., et al.. (1996). Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside. Anti-Cancer Drugs. 7(3). 266–274. 24 indexed citations
19.
Cournoyer, Denis & C. Thomas Caskey. (1993). Gene Therapy of the Immune System. Annual Review of Immunology. 11(1). 297–329. 60 indexed citations
20.
Cournoyer, Denis, Maurizio Scarpa, Stephen N. Jones, et al.. (1990). Gene therapy: A new approach for the treatment of genetic disorders. Clinical Pharmacology & Therapeutics. 47(1). 1–11. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026